Study Finds Per Capita Spending on Patented Drugs Declined -1.8% Over the Last Five Years, While Per Capita Spending on All Other Health Care Grew by 23.2%.
(firmenpresse) - TORONTO, CANADA -- (Marketwired) -- 11/27/13 -- A new study by the sets the facts straight about the cost of patented drugs in Canada. Knowing the truth about drug costs is important. The cost of patented drugs is often cited to justify the regulation of pharmaceutical markets and to restrict public and private insurance coverage of new medicines. Policy decisions made on the basis of bad information can create unintended consequences that affect patients' access to the best available treatments and distort the efficient achievement of desired health outcomes.
The study used the most recent data from two national government agencies, the Patented Medicine Prices Review Board (PMPRB) and the Canadian Institute for Health Information (CIHI), to compare spending on patented drugs versus the rest of health care. The results were published in 's online journal, .
The study establishes the following facts:
The study is available for free download from , the online journal of the and can be accessed at the following web link: .
About CHPI
Canadian Health Policy Institute (CHPI) is a non-profit think-tank funded by independent research grants and unrestricted operating grants from public sector, private sector and non-profit sector sources. CHPI is dedicated to conducting, publishing and communicating evidence-based socio-economic research on health system performance and health policy issues that are important to Canadians.
Contacts:
Canadian Health Policy
Managing Editor
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 27.11.2013 - 05:00 Uhr
Sprache: Deutsch
News-ID 1287375
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
TORONTO, CANADA
Phone:
Kategorie:
Non Profits
Anmerkungen:
Diese Pressemitteilung wurde bisher 305 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Study Finds Per Capita Spending on Patented Drugs Declined -1.8% Over the Last Five Years, While Per Capita Spending on All Other Health Care Grew by 23.2%.
"
steht unter der journalistisch-redaktionellen Verantwortung von
Canadian Health Policy Institute (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
